2009-12-04 15:44:48 -

Emerging Healthcare Solutions, Inc. (PinkSheets: EHSI) today announced the Company has entered into discussions with a Houston-based medical company relating to its patented, and patent pending, genetics technologies. Emerging Healthcare expects the negotiations will result in the companies agreeing to work together to deliver these cutting edge stem cell technologies to national and international medical markets.

The National Institutes of Health recently announced that at least 33 additional embryonic stem cell lines will be added to a national registry. This more than doubles the available stem cell lines that researchers have been able to utilize since a Bush administration moratorium on stem cell lines created after August 9, 2001. The Obama administration recently overturned the moratorium leading to at least 96

additional lines being under review by NIH.

Other publically-held companies involved in stem cell research include Geron Corp. (NASDAQ: GERN), Pfizer, Inc. (NYSE: PFE), and Stem Cells, Inc. (NASDAQ: STEM). The increased access to stem cell lines, concurrent with additional federal research funding should accelerate the delivery of stem cell derived therapies.


About Emerging Healthcare Solutions, Inc.

Emerging Healthcare Solutions, Inc. is a company dedicated to providing guidance to participants in the healthcare industry. Our primary goal is to give you a roadmap showing how to realize enormous profits from the changes occurring right now in the healthcare industry. Our common stock is traded under the symbol EHSI.

For more information, visit www.emerginghealthcaresolutions.com : .

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.



Emerging Healthcare Solutions, Inc.Kathleen Delaney,

713-821-1486